Open calls for proposals - IMI

The Innovative Medicines Initiative (IMI) currently has two Calls for proposals open, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.

IMI2 – Call 10

IMI2 – Call 10, launched in December 2016, is a standard, two-stage Call for proposals and includes the following topics:

  1. Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
  2. How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
  3.  Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain)
  4.  Creation of a pan-European paediatric clinical trials network
  5. Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
  6. Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)
  7. Patient perspectives in medicines lifecycle
  8. Personalised medicine approaches in autism spectrum disorders

 

Deadline for short proposals: 28 March 2017

Call budget: €173 890 000

For more info and call documents follow this link.